Jeffrey R. Marks

发表

Abstract GS5-04: Prediction of occult invasive disease in ductal carcinomain situusing deep learning features

Maciej A. Mazurowski, Bibo Shi, Carlo C. Maley, 2018 .

Multiview mammographic mass detection based on a single shot detection system

Joseph Y. Lo, Yue Geng, Rui Hou, 2019, Medical Imaging.

Mask Embedding for Realistic High-Resolution Medical Image Synthesis

Yingzhou Li, Rui Hou, Joseph Y. Lo, 2019, MICCAI.

Bayesian Regression Analysis in the "Large p, Small n" Paradigm with Application in DNA Microarray S

Mike West, Rainer Spang, Jeffrey R. Marks, 2000 .

Malignant microcalcification clusters detection using unsupervised deep autoencoders

Joseph Y. Lo, Maciej A. Mazurowski, Rui Hou, 2019, Medical Imaging.

Can upstaging of ductal carcinoma in situ be predicted at biopsy by histologic and mammographic features?

Joseph Y. Lo, Maciej A. Mazurowski, Bibo Shi, 2017, Medical Imaging.

Microcalcification localization and cluster detection using unsupervised convolutional autoencoders and structural similarity index

Rui Hou, Joseph Y. Lo, Lars J. Grimm, 2020, Medical Imaging.

Improving classification with forced labeling of other related classes: application to prediction of upstaged ductal carcinoma in situ using mammographic features

Joseph Y. Lo, Maciej A. Mazurowski, Rui Hou, 2018, Medical Imaging.

DNA Microarray Data Analysis and Regression Modeling for Genetic Expression Profiling

Rainer Spang, Jeffrey R. Marks, Joseph R. Nevins, 2000 .

Learning better deep features for the prediction of occult invasive disease in ductal carcinoma in situ through transfer learning

Joseph Y. Lo, Maciej A. Mazurowski, Rui Hou, 2018, Medical Imaging.

Can BI-RADS features on mammography be used as a surrogate for expensive genomic testing in breast cancer patients?

Maciej A. Mazurowski, Jeffrey R. Marks, Michael R. Harowicz, 2017, Medical Imaging.

Prediction and uncertainty in the analysis of gene expression profiles

Mike West, Rainer Spang, Joseph Nevins, 2002, Silico Biol..

Decision Fusion of Circulating Markers for Breast Cancer Detection in Premenopausal Women

Sayan Mukherjee, Joseph Y. Lo, Jeffrey R. Marks, 2007, 2007 IEEE 7th International Symposium on BioInformatics and BioEngineering.

Synthesis and texture manipulation of screening mammograms using conditional generative adversarial network

Joseph Y. Lo, Rui Hou, Lars J. Grimm, 2019, Medical Imaging.

A multitask deep learning method in simultaneously predicting occult invasive disease in ductal carcinoma in-situ and segmenting microcalcifications in mammography

Maciej A. Mazurowski, Rui Hou, Joseph Y. Lo, 2020, Medical Imaging.

Prediction of occult invasive disease in ductal carcinoma in situ using computer-extracted mammographic features

Joseph Y. Lo, Maciej A. Mazurowski, Bibo Shi, 2017, Medical Imaging.

Retina-Match: Ipsilateral Mammography Lesion Matching in a Single Shot Detection Pipeline

Sora C. Yoon, Lars J. Grimm, Jeffrey R. Marks, 2021, MICCAI.

Advances in Brief A SAGE ( Serial Analysis of Gene Expression ) View of Breast Tumor Progression 1

Jeffrey R. Marks, Kornelia Polyak, G. Riggins, 2001 .

Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set

Maciej A. Mazurowski, Jeffrey R. Marks, Ashirbani Saha, 2018, Breast Cancer Research and Treatment.

Association between DNA Damage Response and Repair Genes and Risk of Invasive Serous Ovarian Cancer

Jeffrey R. Marks, Merlise A. Clyde, Edwin S. Iversen, 2010, PloS one.

Role of Eotaxin-1 Signaling in Ovarian Cancer

Jeffrey R. Marks, Anna E. Lokshin, A. Lokshin, 2009, Clinical Cancer Research.

High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer

Susan K. Murphy, Jeffrey R. Marks, Yaqing Wen, 2006, Nucleic acids research.

Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23

Jeffrey R. Marks, Ken C. Q. Nguyen, Jing Li, 2002, Nature Genetics.

Erratum: Genomic signatures to guide the use of chemotherapeutics (Nature Medicine (2006) 12 (1294-1300))

Anil Potti, Andrea Bild, Jeffrey R. Marks, 2011 .

Loss of ARID1A-Associated Protein Expression is a Frequent Event in Clear Cell and Endometrioid Ovarian Cancers

Jeffrey R. Marks, David Huntsman, Rex Bentley, 2012, International Journal of Gynecologic Cancer.